Mouh Fatima Zahra, Slaoui Meriem, Razine Rachid, El Mzibri Mohammed, Amrani Mariam
Equipe de recherche ONCOGYMA, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Rabat, Morocco.
Unité de Biologie et Recherche Médicale, Centre National de l'Energie, des Sciences et des Techniques Nucléaires, Rabat, Morocco.
Breast Cancer (Auckl). 2020 Apr 29;14:1178223420906428. doi: 10.1177/1178223420906428. eCollection 2020.
Triple-negative breast cancer (TNBC) is a group of breast carcinoma characterized by the lack of expression of estrogen and progesterone hormone receptors (ER, PgR) and HER2. This form is also characterized by its aggressiveness, a low survival rate, and the absence of targeted therapies. This study was planned to evaluate the clinical features, treatment, and prognosis characteristics of TNBC in a population of Moroccan patients.
In this retrospective study, a total of 905 patients diagnosed with breast cancer at the National Institute of Oncology in Rabat, Morocco, have been included. Based on molecular subtype, patients were divided into 2 categories: TNBC and non-TNBC patients. Data were recorded from patients' medical files and analyzed using SPSS 13.0 software (IBM).
Overall, 17% of the patients had TNBC. At diagnosis, the median age of TNBC cases was 47 years, with extreme ages of 40 and 55 years. The median follow-up time was 30 months (10-53 months) and the 3-year survival rate was 76%. No significant difference was observed among the patients in terms of age at diagnosis, age at menarche, age at the time of first birth, nulliparity, oral contraception, and family history of breast cancer. Menopausal status and the number of pregnancy were significantly higher in the non-TNBC group. The percentage of grade 3 (G3) tumors was higher in the TNBC group ( < .001). Using neoadjuvant, adjuvant chemotherapy and radiotherapy, a net benefit in the event-free survival was registered for the 2 groups.
This retrospective study was very informative and showed that women with TNBC had a less favorable prognosis than non-TNBC cases. Clinical data demonstrated that risk factors including age, premenopausal status, parity, hormonal contraceptive use, advanced disease, and a high histologic grade were independently associated with TNBC. However, large tumors and high Scarff-Bloom and Richardson grade prevail in TNBC cases with a higher incidence of lymph node metastases.
三阴性乳腺癌(TNBC)是一组乳腺癌,其特征是缺乏雌激素和孕激素受体(ER、PgR)以及HER2的表达。这种类型还具有侵袭性、低生存率以及缺乏靶向治疗的特点。本研究旨在评估摩洛哥患者群体中TNBC的临床特征、治疗和预后特征。
在这项回顾性研究中,纳入了摩洛哥拉巴特国家肿瘤研究所诊断为乳腺癌的905例患者。根据分子亚型,患者分为两类:TNBC患者和非TNBC患者。数据从患者的医疗档案中记录,并使用SPSS 13.0软件(IBM)进行分析。
总体而言,17%的患者患有TNBC。在诊断时,TNBC病例的中位年龄为47岁,极端年龄为40岁和55岁。中位随访时间为30个月(10 - 53个月),3年生存率为76%。在诊断时的年龄、初潮年龄、首次生育年龄、未生育、口服避孕药以及乳腺癌家族史方面,患者之间未观察到显著差异。非TNBC组的绝经状态和怀孕次数显著更高。TNBC组中3级(G3)肿瘤的百分比更高(<0.001)。使用新辅助、辅助化疗和放疗,两组在无事件生存方面均有净获益。
这项回顾性研究提供了很多信息,并表明TNBC女性的预后比非TNBC病例更差。临床数据表明,年龄、绝经前状态、生育情况、激素避孕药使用、疾病晚期以及高组织学分级等危险因素与TNBC独立相关。然而,TNBC病例中存在大肿瘤以及高斯卡夫-布卢姆和理查森分级,且淋巴结转移发生率更高。